Annual Total Liabilities
$4.11 M
+$2.84 M+225.18%
December 1, 2023
Summary
- As of February 9, 2025, BLAC annual total liabilities is $4.11 million, with the most recent change of +$2.84 million (+225.18%) on December 1, 2023.
- During the last 3 years, BLAC annual total liabilities has risen by +$3.79 million (+1177.46%).
- BLAC annual total liabilities is now at all-time high.
Performance
BLAC Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$6.01 M
+$523.00 K+9.53%
September 1, 2024
Summary
- As of February 9, 2025, BLAC quarterly total liabilities is $6.01 million, with the most recent change of +$523.00 thousand (+9.53%) on September 1, 2024.
- Over the past year, BLAC quarterly total liabilities has stayed the same.
- BLAC quarterly total liabilities is now at all-time high.
Performance
BLAC Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
BLAC Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +225.2% | 0.0% |
| 3 y3 years | +1177.5% | 0.0% |
| 5 y5 years | +1177.5% | 0.0% |
BLAC Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +480.9% | at high | +750.0% |
| 5 y | 5-year | at high | +1177.5% | at high | +750.0% |
| alltime | all time | at high | +1177.5% | at high | +750.0% |
Bellevue Life Sciences Acquisition Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.01 M(+9.5%) |
| Jun 2024 | - | $5.49 M(+14.0%) |
| Mar 2024 | - | $4.82 M(+17.2%) |
| Dec 2023 | $4.11 M | $4.11 M(+29.4%) |
| Sep 2023 | - | $3.18 M(+21.6%) |
| Jun 2023 | - | $2.61 M(+5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $2.47 M(+95.8%) |
| Dec 2022 | $1.26 M(+78.6%) | $1.26 M(+6.6%) |
| Sep 2022 | - | $1.19 M(+11.6%) |
| Jun 2022 | - | $1.06 M(+50.2%) |
| Dec 2021 | $707.20 K(+119.9%) | $707.20 K |
| Dec 2020 | $321.60 K | - |
FAQ
- What is Bellevue Life Sciences Acquisition annual total liabilities?
- What is the all time high annual total liabilities for Bellevue Life Sciences Acquisition?
- What is Bellevue Life Sciences Acquisition annual total liabilities year-on-year change?
- What is Bellevue Life Sciences Acquisition quarterly total liabilities?
- What is the all time high quarterly total liabilities for Bellevue Life Sciences Acquisition?
- What is Bellevue Life Sciences Acquisition quarterly total liabilities year-on-year change?
What is Bellevue Life Sciences Acquisition annual total liabilities?
The current annual total liabilities of BLAC is $4.11 M
What is the all time high annual total liabilities for Bellevue Life Sciences Acquisition?
Bellevue Life Sciences Acquisition all-time high annual total liabilities is $4.11 M
What is Bellevue Life Sciences Acquisition annual total liabilities year-on-year change?
Over the past year, BLAC annual total liabilities has changed by +$2.84 M (+225.18%)
What is Bellevue Life Sciences Acquisition quarterly total liabilities?
The current quarterly total liabilities of BLAC is $6.01 M
What is the all time high quarterly total liabilities for Bellevue Life Sciences Acquisition?
Bellevue Life Sciences Acquisition all-time high quarterly total liabilities is $6.01 M
What is Bellevue Life Sciences Acquisition quarterly total liabilities year-on-year change?
Over the past year, BLAC quarterly total liabilities has changed by $0.00 (0.00%)